Cleared Special

K081389 - ACCU-CHEK COMPACT PLUS BLOOD GLUCOSE MONITORING SYSTEM (FDA 510(k) Clearance)

Jul 2008
Decision
57d
Days
Class 2
Risk

K081389 is an FDA 510(k) clearance for the ACCU-CHEK COMPACT PLUS BLOOD GLUCOSE MONITORING SYSTEM. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on July 15, 2008, 57 days after receiving the submission on May 19, 2008.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K081389 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 2008
Decision Date July 15, 2008
Days to Decision 57 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code NBW — System, Test, Blood Glucose, Over The Counter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345

Similar Devices — NBW System, Test, Blood Glucose, Over The Counter

All 14
On Call® Sure GK Blood Glucose & Ketone Monitoring System
K250085 · ACON Laboratories, Inc. · Oct 2025
RIGHTEST Blood Glucose Monitoring System Max Tel
K240637 · Bionime Corporation · Nov 2024
RIGHTEST Blood Glucose Monitoring System Max Tel
K231192 · Bionime Corporation · Jan 2024
ReliOn Premier BLU Blood Glucose Monitoring System
K230625 · I-Sens, Inc. · Aug 2023
GlucoSure ADVANCE Link Blood Glucose Monitoring System
K222234 · Apex BioTechnology Corp. · Dec 2022
BGM039 Blood Glucose Monitoring System, BGM039 Link Blood Glucose Monitoring System
K220421 · Apex BioTechnology Corp. · Nov 2022